INTRODUCTION {#s1}
============

One key means by which transcription is regulated is through changes to covalent modifications that occur on nucleosomal histone proteins that comprise chromatin ([@DEV182568C5]). The enzymes that add or remove these modifications play crucial roles during development and their dysregulation can lead to a number of different human disorders ([@DEV182568C42]). Lysine demethylase 5 (KDM5) family proteins are chromatin-mediated regulators of transcription that are encoded by four paralogous genes in mammalian cells, KDM5A, KDM5B, KDM5C and KDM5D, and by a single gene in *Drosophila*, *kdm5* (also known as *little imaginal discs*; *lid*). The most well-established gene regulatory function of KDM5 proteins is their enzymatic activity, which demethylates trimethylated lysine 4 of histone H3 (H3K4me3) ([@DEV182568C1]; [@DEV182568C71]). High levels of H3K4me3 are found surrounding transcriptional start sites and are associated with active gene expression ([@DEV182568C59]). Whereas absolute levels of H3K4me3 are unlikely to be primary drivers of gene expression levels, the breadth of these promoter peaks can impact transcriptional consistency ([@DEV182568C7]; [@DEV182568C26]). Recruitment of KDM5 to promoters to demethylate H3K4me3 is therefore one mechanism by which this family of proteins regulates transcription. KDM5 proteins can also affect gene expression through demethylase-independent mechanisms, such as through interactions with the chromatin remodeling NuRD complex or by regulating histone acetylation via interactions with lysine deacetylase (HDAC) complexes ([@DEV182568C6]; [@DEV182568C21]; [@DEV182568C33]; [@DEV182568C36]; [@DEV182568C47]).

KDM5 proteins play key roles in orchestrating diverse gene expression programs. This is emphasized by the large volume of literature linking dysregulation of KDM5 proteins to two seemingly disparate clinical outcomes: cancer and intellectual disability. Whole-exome sequencing of individuals with intellectual disability has identified loss of function mutations in KDM5A, KDM5B and KDM5C ([@DEV182568C15]; [@DEV182568C30]; [@DEV182568C69]). Efforts to understand the link between KDM5 and intellectual disability using mice, flies and worms have revealed that KDM5 can regulate many genes that impact neuronal development or function ([@DEV182568C13]; [@DEV182568C29]; [@DEV182568C38]; [@DEV182568C77]). However, the extent to which any of these pathways contribute to the cognitive impairments observed in patients remains unknown. A similar deficit exists in our understanding of how the dysregulation of human KDM5 genes contributes to cancer ([@DEV182568C8]; [@DEV182568C54]). In contrast to intellectual disability, which is exclusively associated with loss-of-function mutations in KDM5 genes, malignancies have been associated with overexpression of KDM5A or KDM5B, either loss or gain of KDM5C, or loss of KDM5D. The best studied of these is the overexpression of KDM5B observed in breast cancer and melanoma, which correlates with poor prognosis ([@DEV182568C25]). Despite being shown to directly or indirectly regulate genes involved in cell cycle progression, cancer stem cell survival and DNA repair, no clear model has emerged to explain its oncogenic capacities ([@DEV182568C12]; [@DEV182568C25]; [@DEV182568C41]; [@DEV182568C57]; [@DEV182568C73]; [@DEV182568C75]). Our lack of understanding of KDM5-regulated pathways that lead to clinical disorders underscores the importance of defining the physiological functions of KDM5 proteins.

*Drosophila melanogaster* offers a genetically amenable model for providing fundamental insight into KDM5 function *in vivo*, as it encodes a single, highly conserved, *kdm5* gene ([@DEV182568C23]). Moreover, in contrast to knockouts of KDM5A, KDM5B or KDM5C in mice that are homozygous viable, loss of *Drosophila kdm5* results in lethality ([@DEV182568C4]; [@DEV182568C18]; [@DEV182568C29]; [@DEV182568C31]; [@DEV182568C39]). This allows us to dissect crucial functions of KDM5 without the complication of functional redundancy between mammalian KDM5 paralogs that could partially occlude phenotypes. We have previously shown that *kdm5* null mutants take 5 days longer than wild-type animals to complete larval development, linking KDM5 function to growth control. Interestingly, this phenotype is independent of the histone demethylase activity of KDM5, as animals specifically lacking this enzymatic function grow normally and produce viable adult flies ([@DEV182568C18]; [@DEV182568C34]). Emphasizing the importance of understanding cellular functions of KDM5 proteins that are independent of their enzymatic activity, the contribution of the demethylase function of KDM5 to normal development and to clinical disorders in mammalian cells remains unresolved. For example, although some intellectual disability-associated mutations in KDM5C reduce *in vitro* histone demethylase activity, others do not ([@DEV182568C10]; [@DEV182568C28]; [@DEV182568C66]; [@DEV182568C70]). Similarly, whereas the growth of some cancers can be attenuated by pharmacologically inhibiting KDM5 demethylase activity, KDM5 appears to act through demethylase-independent activities in others ([@DEV182568C11]; [@DEV182568C53]). KDM5 proteins are therefore likely to use more than one gene-regulatory activity to control a range of cellular processes *in vivo.*

Here, we demonstrate that KDM5 regulates larval development by playing an essential role in the prothoracic gland, a tissue that secretes the steroid hormone ecdysone, which is a key regulator of animal growth and maturation ([@DEV182568C74]). Although KDM5 is normally expressed ubiquitously during larval development, re-expression of *kdm5* exclusively in the prothoracic gland within a *kdm5* null mutant background rescues the larval growth delay and restores adult viability. We further show that within cells of the prothoracic gland, KDM5 is necessary to promote the endoreplicative cell cycles that increase DNA copy number and is required for the transcription of enzymes that mediate ecdysone production ([@DEV182568C51]). Crucial to the prothoracic gland functions of KDM5 is its regulation of the Torso receptor tyrosine kinase, which activates the MAPK pathway to trigger ecdysone production ([@DEV182568C55]; [@DEV182568C63]). By identifying KDM5 as a new transcriptional regulator of this signaling cascade, our data provide new insights into the molecular mechanisms governing the regulation of ecdysone production and developmental growth control.

RESULTS {#s2}
=======

KDM5 expression in the prothoracic gland is sufficient to rescue lethality and restore correct developmental timing to *kdm5* null mutants {#s2a}
------------------------------------------------------------------------------------------------------------------------------------------

To understand the underlying basis of the lethality caused by the *kdm5^140^* null allele, we sought to define the spatial requirements of KDM5 function during development. To do this, we re-expressed *kdm5* within different tissues of the null mutant using a Gal4-inducible transgene that we have previously used to rescue hypomorphic alleles of *kdm5* ([@DEV182568C34]) ([Table 1](#DEV182568TB1){ref-type="table"}). Ubiquitous expression of this UAS-*kdm5* transgene using Ubiquitin-Gal4 (Ubi-Gal4) resulted in slightly higher than endogenous levels of KDM5 expression and rescued the lethality of *kdm5^140^* ([Fig. 1](#DEV182568F1){ref-type="fig"}A; [Table 1](#DEV182568TB1){ref-type="table"}). Re*-*expressing *kdm5* ubiquitously also led to a developmental timing profile that was similar to that of wild-type flies ([Fig. 1](#DEV182568F1){ref-type="fig"}B). This is consistent with the observation by us and others that KDM5 is broadly expressed in all cell types examined to date ([@DEV182568C33]; [@DEV182568C36]; [@DEV182568C45]; [@DEV182568C61]; [@DEV182568C67]; [@DEV182568C77]). Table 1.**Re-expressing *kdm5* in defined tissues in *kdm5^140^* mutants** Fig. 1.**KDM5 expression in the prothoracic gland rescues the *kdm5^140^* developmental delay and lethality.** (A) Western blot using 3rd instar larval wing imaginal discs (five per lane) from wild type, *kdm5^140^* (no Gal4 driver) and *kdm5^140^* expressing *kdm5* ubiquitously (*kdm5^140^*; Ubi\>*kdm5*). Anti-KDM5 (top panel) is indicated by the arrowhead. Anti-α-tubulin is used as a loading control (bottom panel). (B) Number of days taken for pupariation to occur in wild type (*n=*82), *kdm5^140^* (*n=*49), *kdm5^140^*; Ubi\>*kdm5* (*n=*69), *kdm5^140^*; Mai60\>*kdm5* (*n=*63) and *kdm5^140^* ; spok\>*kdm5* (*n=*74). Data are mean±s.e.m. (C) Number of days taken for pupariation to occur in control (spok\>*w^1118^*; *n=*417) and spok\>*kdm5* animals (*n=*666). Data are mean±s.e.m. (D) Adult survival for *kdm5^140^*; Ubi\>*kdm5* (*n=*56), *kdm5^140^*; Mai60\>*kdm5* (*n=*62) and *kdm5^140^*; spok\>*kdm5* (*n=*51) rescued male flies. Mai60 and spok-Gal4-rescued flies are significantly shorter lived than Ubi-Gal4-rescued flies (Mantel-Cox log-rank test; *P*\<0.0001). (E) Male wild-type fly (*kdm5^140^*; g\[*kdm5*:HA\]attp86F). (F) Male *kdm5^140^*; Ubi\>*kdm5* adult fly showing morphologically normal features. (G) Male *kdm5^140^*; Mai60\>*kdm5* adult fly with normal body and slightly curved wings indicated by an arrow. (H) Male *kdm5^140^*; spok\>*kdm5* adult fly with normal body and curved wings indicated by an arrow. Scale bars: 500 µm.

To test whether KDM5 plays key developmental roles in specific tissues, we tested a range of Gal4 drivers for their ability to rescue *kdm5^140^* lethality when combined with UAS-*kdm5* ([Table 1](#DEV182568TB1){ref-type="table"}). These included strains that drive Gal4 expression in tissues that have phenotypes in *kdm5* mutant or knockdown larvae, such as imaginal discs and hemocytes ([@DEV182568C18]; [@DEV182568C44]; [@DEV182568C45]). In addition, we tested tissues linked to the regulation of larval growth, such as the hormone-producing larval prothoracic gland, insulin secreting cells of the brain and cells of the fat body that coordinate larval growth with feeding and nutritional status ([@DEV182568C74]). Significantly, all Gal4 drivers that were expressed in the larval prothoracic gland significantly rescued *kdm5^140^* lethality, including spookier-Gal4 (spok-Gal4), which is expressed exclusively in this tissue ([Table 1](#DEV182568TB1){ref-type="table"}) ([@DEV182568C27]; [@DEV182568C43]; [@DEV182568C63]). Consistent with KDM5 playing crucial functions in the ecdysone-secreting larval prothoracic gland, spok-Gal4-mediated re-expression of *kdm5* was sufficient to rescue the developmental delay *kdm5^140^* ([Fig. 1](#DEV182568F1){ref-type="fig"}B). Interestingly, UAS-mediated expression of *kdm5* in a wild-type background did not accelerate normal growth rate, suggesting that KDM5 is necessary but not sufficient for prothoracic gland function during larval development ([Fig. 1](#DEV182568F1){ref-type="fig"}C).

It is notable that while expression of *kdm5* in the prothoracic gland allowed *kdm5^140^* mutant animals to eclose, adult flies were shorter-lived than flies expressing *kdm5* ubiquitously ([Fig. 1](#DEV182568F1){ref-type="fig"}D). In addition, while adults rescued by ubiquitous expression of *kdm5* were largely male and female fertile, prothoracic gland re-expression of *kdm5* resulted in significant infertility ([Table 2](#DEV182568TB2){ref-type="table"}). These data are consistent with previous observations showing roles for KDM5 in oogenesis and in testis germline stem cell proliferation ([@DEV182568C46]; [@DEV182568C67]; [@DEV182568C78]). Together, these studies demonstrate essential roles for KDM5 in the larval prothoracic gland and in other cell types that are important for adult survival and reproduction.Table 2.**Fertility of *kdm5^140^*-rescued adult flies**

These rescue studies also revealed a role for KDM5 in wing development. While adult flies generated by re-expression of *kdm5* in the prothoracic gland, such as spok-Gal4, were the same size as those rescued by ubiquitous expression, they had wings that were curved downward compared with wild type ([Fig. 1](#DEV182568F1){ref-type="fig"}E-H). A similar curved-down wing phenotype was observed in *kdm5^140^* flies that expressed *kdm5* in the wing imaginal disc in addition to the prothoracic gland such as Mai60-Gal4 or 32B-Gal4, but not with more broadly expressed drivers such as T80-Gal4 ([Fig. 1](#DEV182568F1){ref-type="fig"}G, [Table 1](#DEV182568TB1){ref-type="table"}). This curved-wing phenotype could be caused by the proliferative or cell death phenotypes we previously observed in *kdm5^140^* larval wing imaginal discs ([@DEV182568C18]). To test this, we quantified wing disc proliferation and cell death using antibodies that detect the mitotic marker phosphorylated histone H3 (pH3) and the cleaved caspase Dcp-1, respectively. As expected, the decreased levels of pH3 observed by western blot and whole-mount staining of *kdm5^140^* wing imaginal discs were fully restored by ubiquitous *kdm5* expression using Ubi-Gal4 ([Fig. 2](#DEV182568F2){ref-type="fig"}A-I). The reduced levels pH3 seen in *kdm5^140^* were similarly rescued by expressing *kdm5* under the control of Mai60-Gal4 or spok-Gal4 that drives low or no KDM5 expression in the wing disc, respectively ([Fig. 2](#DEV182568F2){ref-type="fig"}B-I). Likewise, the increased number of Dcp-1-positive cells seen in *kdm5^140^* wing discs was restored to wild-type levels by Mai60-Gal4 or spok-Gal4-driven expression of *kdm5* ([Fig. 2](#DEV182568F2){ref-type="fig"}J-O). Thus, neither the proliferative nor the apoptotic phenotypes of *kdm5^140^* wing imaginal discs are triggered by loss of KDM5 in the disc itself but are caused by cell-nonautonomous mechanisms. Although the basis for the wing defects observed in Mai-60 and spok-Gal4 rescued flies remains unclear, it could be due to a requirement for KDM5 during pupal development or during wing maturation in newly eclosed flies. Fig. 2.**Increased cell death and reduced proliferation in *kdm5^140^* wing discs is due to non-cell autonomous effects.** (A) Western blot using anti-KDM5 (top), anti-phosphorylated histone H3 (middle; pH3) and total histone H3 (bottom; H3) in wild-type and *kdm5^140^* wing discs. Six wing discs per lane. (B) Western blot using wing discs from *kdm5^140^* mutants re-expressing *kdm5* using Ubi-Gal4, Mai60-Gal4 or spok-Gal4. Anti-KDM5 (top panel), pH3 (middle panel) and total H3 (bottom panel). Six wing discs per lane. Arrowheads indicate KDM5. (C) Quantification of the levels of pH3 relative to total H3 from three western blots. \*\**P*\<0.01 (one-way ANOVA); ns, not significant. Data are mean± s.e.m. (D-H) Anti-pH3 staining of wing imaginal disc from (D) a wild-type wandering 3rd instar larva, (E) a *kdm5^140^* wandering 3rd instar larva, (F) *kdm5^140^*; Ubi\>*kdm5* wandering 3rd instar larva, (G) a *kdm5^140^*; Mai60\>*kdm5* wandering 3rd instar larva and (H) a *kdm5^140^*; spok\>*kdm5* wandering 3rd instar larva. Dotted oval indicates wing pouch region used for quantification. (I) Quantification of the number of pH3-positive cells in the pouch region of wild type (*n=*3), *kdm5^140^* (*n=*4), *kdm5^140^*; Ubi\>*kdm5* (*n=*4), *kdm5^140^*; Mai60\>*kdm5* (*n=*3), *kdm5^140^*; spok\>*kdm5* (*n=*6). \*\*\*\**P*\<0.0001 (one-way ANOVA). Data are mean±s.e.m. with individual data points indicated. (J-N) A wild-type wing imaginal disc (J), a *kdm5^140^* mutant wing imaginal disc (K), a wing imaginal disc from *kdm5^140^*; Ubi\>*kdm5* (L), a wing imaginal disc from *kdm5^140^*; Mai60\>*kdm5* (M) and a wing imaginal disc from *kdm5^140^*; spok\>*kdm5* (N) from wandering 3rd instar larvae stained using the apoptosis marker anti-Dcp-1. Dotted circle indicates pouch region of the wing disc that was used to count Dcp-1-positive cells. (O) Quantification of the number of Dcp-1 positive cells in the pouch region of wing imaginal discs from wild type (*n=*12), *kdm5^140^* (*n=*7), *kdm5^140^*; Ubi\>*kdm5* (*n=*9)*, kdm5^140^*; Mai60\>*kdm5* (*n=*7) and *kdm5^140^*; spok\>*kdm5* (*n=*8)*.* \*\*\*\**P*\<0.0001, \*\*\**P*\<0.001, \**P*\<0.05 (one-way ANOVA). Data are mean±s.e.m. with individual data points indicated.

Reduced ecdysone production causes the developmental delay of *kdm5^140^* mutant larvae {#s2b}
---------------------------------------------------------------------------------------

The prothoracic gland, corpus allatum and corpora cardiaca are the three sub-tissues that make up the larval ring gland: a semi-circular structure associated with the central larval brain. Whereas the prothoracic gland synthesizes ecdysone, the corpus allatum and corpora cardiaca produce juvenile hormone and adipokinetic hormone, respectively ([@DEV182568C58]). In order to evaluate the role of KDM5 in these two other sub-tissues, we tested whether expressing *kdm5* in the corpus allatum rescued the lethality of *kdm5^140^* using Aug21-Gal4 ([Table 1](#DEV182568TB1){ref-type="table"}) ([@DEV182568C2]; [@DEV182568C64]). In contrast to expression in the prothoracic gland, no significant rescue was observed when *kdm5* was reintroduced into the corpus allatum. Similarly, expression of *kdm5* in the corpora cardiaca using Akh-Gal4 failed to rescue *kdm5^140^* mutants ([@DEV182568C32]) ([Table 1](#DEV182568TB1){ref-type="table"}). Thus, within the ring gland, KDM5 is crucial only for prothoracic gland function, linking its transcriptional regulatory functions to ecdysone biology.

Based on the requirement for KDM5 in the prothoracic gland, we tested whether *kdm5^140^* larvae had altered levels of the active form of ecdysone (20-hydroxyecdysone; 20E). These analyses revealed that *kdm5^140^* larvae that were matched to controls by developmental stage had a threefold reduction in 20E levels and concomitant reduction in the expression of ecdysone-regulated genes such as *broad*, *E74* and *E75* ([Fig. 3](#DEV182568F3){ref-type="fig"}A,B). Ecdysone is synthesized in the prothoracic gland from cholesterol through the action of a series of biosynthetic enzymes that include Noppera-bo (Nobo), Neverland (Nvd), Spookier (Spok), Shoud (Sro), Phantom (Phm), Disembodied (Dib) and Shadow (Sad) ([@DEV182568C22]; [@DEV182568C48]). qPCR analyses to examine the expression of the genes that encode these proteins revealed that *nvd*, *spok, sro*, *dib* and *sad* transcripts were significantly decreased in *kdm5^140^* mutant 3rd instar larvae ([Fig. 3](#DEV182568F3){ref-type="fig"}C). While *nobo* and *phm* trended toward being similarly reduced in *kdm5^140^* larvae, these did not meet statistical significance ([Fig. 3](#DEV182568F3){ref-type="fig"}D). We also examined levels of the hydroxylase Shade (Shd), which is necessary for converting ecdysone into 20E in peripheral cells of the larva, and found it to be unaffected by loss of KDM5 ([Fig. 3](#DEV182568F3){ref-type="fig"}D). *kdm5^140^* mutants are therefore likely to have reduced 20E owing to a defect in ecdysone biosynthesis in the prothoracic gland. Fig. 3.**Exogenous ecdysone rescues the developmental delay of *kdm5^140^* mutants.** (A) Quantification of 20E levels in pg per larva using wild-type, *kdm5^140^*, *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; Mai60\>*kdm5* and *kdm5^140^*; spok\>*kdm5* whole 3rd instar larvae. \*\*\*\**P*\<0.001 (one-way ANOVA). Data are mean± s.e.m. (B) Real-time PCR of biological triplicate samples quantifying the mRNA levels of the ecdysone target genes *broad*, *E74* and *E75* in wild-type, *kdm5^140^*, *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; Mai60\>*kdm5* or *kdm5^140^*; spok\>*kdm5* whole 3rd instar larvae. Data were normalized to *rp49* and are shown relative to wild type. \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 (one-way ANOVA). Error bars indicate s.e.m. (C) Real-time PCR from biological triplicate samples quantifying the mRNA levels of the ecdysone biosynthetic genes *nvd*, *spok*, *dib*, *sro* and *sad* in wild-type, *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; Mai60\>*kdm5* or *kdm5^140^*; spok\>*kdm5* whole 3rd instar larvae*.* Data were normalized to *rp49* and are shown relative to wild type. \**P*=0.05, \*\**P*\<0.01, \*\*\**P*\<0.001 (one-way ANOVA). Error bars indicate s.e.m. (D) Real-time PCR of biological triplicate samples quantifying the mRNA levels of *phm*, *nobo* and *Shade* in wild-type or *kdm5^140^* whole 3rd instar larvae*.* Data were normalized to *rp49* and are shown relative to wild type. Error bars indicate s.e.m. No significant difference was observed (Student\'s *t*-test). (E) Quantification of the time for pupariation to occur upon feeding 20E to wild type (*n=*103) and *kdm5^140^* (*n=*62) or vehicle alone (ethanol) to wild-type (*n=*67) or *kdm5^140^* (*n=*60) animals. (F) Quantification of the time for pupariation to occur upon feeding 7-dehydrocholesterol (7dC) to wild type (*n=*214) and *kdm5^140^* (*n=*117) or vehicle alone (ethanol) to wild-type (*n=*198) and *kdm5^140^* (*n=*128) animals. Data are mean±s.e.m. in E,F. (G) Quantification of the number of pupae that eclosed from their pupal case for wild-type larvae that were fed vehicle alone (20E control, ethanol) (*n=*33) or 20E (*n=*40) or *kdm5^140^* larvae fed vehicle alone (20E control, ethanol) (*n=*16) or 20E (*n=*15), wild-type larvae that were fed vehicle alone (7dC control, ethanol) (*n=*73) or 7dC (*n=*68) or *kdm5^140^* larvae fed vehicle alone (7dC control, ethanol) (*n=*21) or 7dC (*n=*22). No statistical difference between vehicle and 20E or 7dC was observed for wild-type or *kdm5^140^* animals (Student\'s *t*-test).

To test whether re-expression of *kdm5* in the prothoracic gland restored ecdysone production, we quantified levels of 20E in *kdm5^140^* larvae expressing UAS-*kdm5* using Ubi-Gal4, Mai60-Gal4 or spok-Gal4. All three Gal4 drivers restored levels of 20E, the expression of ecdysone-regulated genes and transcription of the ecdysone biosynthetic genes *nvd*, *spok*, *dib* and *sro* to wild-type levels ([Fig. 3](#DEV182568F3){ref-type="fig"}A-C). Based on these data, dietary supplementation with 20E but not the precursor molecule 7-dehydrocholesterol (7dC) would be expected to attenuate the phenotypes caused by loss of KDM5. Consistent with this prediction, exogenously providing 20E but not 7dC rescued the developmental delay of *kdm5* mutant larvae compared with vehicle-only controls ([Fig. 3](#DEV182568F3){ref-type="fig"}E,F). 20E was not, however, able to rescue the eclosion defect of *kdm5^140^* animals, whereas wild-type animals eclosed after ecdysone feeding ([Fig. 3](#DEV182568F3){ref-type="fig"}G). This could be because KDM5 is required for ecdysone production during pupal development when animals are unable to consume 20E-containing food. Alternatively, loss of KDM5 could cause additional defects in the prothoracic gland that are not able to be substituted by restoring 20E. As expected, based on its inability to rescue the developmental delay of *kdm5^140^*, 7dC supplementation did not alter the eclosion defect caused by loss of KDM5 ([Fig. 3](#DEV182568F3){ref-type="fig"}G).

KDM5 regulates the Torso/MAPK signaling pathway and prothoracic gland endocycles {#s2c}
--------------------------------------------------------------------------------

To investigate the basis of the reduced ecdysone levels, we examined the activity of two key pathways known to regulate its production: the insulin receptor and Torso/MAPK pathways ([@DEV182568C74]). Activation of the insulin receptor by insulin-like peptides leads to the phosphorylation of Akt, which subsequently induces cell growth and ecdysone production ([@DEV182568C16]; [@DEV182568C51]). To test whether this pathway was affected by the loss of KDM5, we examined levels of phosphorylated Akt compared with total Akt in *kdm5^140^* ring glands by western blot ([Fig. 4](#DEV182568F4){ref-type="fig"}A,B). We also quantified mRNA levels of the insulin receptor (InR) in brain-ring gland complexes ([Fig. 4](#DEV182568F4){ref-type="fig"}C). Neither of these signaling components were affected in *kdm5^140^* larvae, suggesting that this pathway was unlikely to mediate the developmental delay caused by loss of KDM5. Fig. 4.**Levels and activity of the Torso receptor pathway are reduced in *kdm5^140^*.** (A) Western blot analyses of wild-type and *kdm5^140^* dissected ring glands examining levels of phosphorylated Akt (pAkt; top) and total Akt (bottom) as a control. Six rings glands per lane. (B) Quantification of triplicate western blots showing the ratio of pAkt to total Akt in *kdm5^140^* compared with wild type. ns, not significant (Student\'s *t*-test). Error bars indicate s.e.m. (C) Real-time PCR of biological triplicate samples quantifying the average mRNA levels of *InR* in dissected brain-ring gland complexes from wild-type and *kdm5^140^* 3rd instar larvae. Data were normalized to *rp49* and shown relative to wild type. ns, not significant (Student\'s *t*-test). Error bars indicate s.e.m. (D) Western blot analyses of wild-type and *kdm5^140^* dissected ring glands examining levels of phosphorylated ERK (pERK; top) and total ERK (bottom) as a control. Five ring glands per lane. (E) Quantification of triplicate western blots showing the ratio of pERK to total ERK in *kdm5^140^* compared with wild type. \*\**P*\<0.01 (Student\'s *t*-test). Error bars indicate s.e.m. (F) Real-time PCR from biological triplicate samples quantifying the average mRNA levels of *torso* in dissected brain-ring gland complexes from wild type and *kdm5^140^* 3rd instar larvae. Data were normalized to *rp49* and are shown relative to wild type. \*\**P*=0.0026 (Student\'s *t*-test). Error bars indicate s.e.m. (G) Number of days taken for pupariation to occur in wild-type (*n=*642) *kdm5^140^* (*n=*141), *kdm5^140^*; spok\>*kdm5* (*n=*147), *kdm5^140^*; spok\>*torso* (*n=*153) and *kdm5^140^*; spok\>*Ras^V12^* (*n=*150) animals*.* (H) Male wild-type fly (*kdm5^140^*; g\[*kdm5*:HA\]attp86F). (I) Male *kdm5^140^*; spok\>*torso* adult fly with normal body and curved down wings indicated by an arrow. (J) Male *kdm5^140^*; spok\>*Ras^V12^* adult fly with normal body and curved wings indicated by an arrow. Number of days taken for pupariation to occur in wild-type control (spok\>*w^1118^*; *n=*417), spok\>*torso* (*n=*474) and spok\>*Ras^V12^* (*n=*378) animals. Scale bars: 500 µm. Data are mean±s.e.m. in G,K.

Ecdysone production can also be regulated by activation of the Torso receptor by prothoracicotropic hormone (PTTH), which functions by activating a Ras/ERK MAP kinase cascade ([@DEV182568C48]; [@DEV182568C50]; [@DEV182568C74]). To test whether the Torso/MAPK pathway was altered in *kdm5* null mutant larvae, we examined levels of phosphorylated ERK relative to total ERK in addition to mRNA levels of the *torso* receptor ([Fig. 4](#DEV182568F4){ref-type="fig"}D-F). Both phosphorylated ERK and *torso* expression were significantly decreased compared with wild type, suggesting that loss of KDM5 caused a defect in this pathway. To examine the functional role that the Torso/MAPK pathway played in the developmental delay and lethality of *kdm5^140^*, we expressed a UAS transgene encoding wild-type Torso or a constitutively activated form of the downstream GTPase Ras (Ras^V12^). Expression of *torso* or *Ras^V12^* using spok-Gal4 restored the developmental delay defect and also rescued the lethality of *kdm5^140^* to produce adults that showed a curved-down wing phenotype similar to that seen upon re-expression of *kdm5* ([Fig. 4](#DEV182568F4){ref-type="fig"}G-J; [Table 3](#DEV182568TB3){ref-type="table"}). Expression of *torso* or *Ras^V12^* using spok-Gal4 did not alter developmental timing in a wild-type background ([Fig. 4](#DEV182568F4){ref-type="fig"}K). These data are consistent with the reduced Torso/MAPK signaling observed in *kdm5^140^* playing a key role in mediating the prothoracic gland activities of KDM5.Table 3.**Rescue of *kdm5* lethality by UAS-transgene expression**

Torso/MAPK activation by PTTH has been linked to the regulation of prothoracic gland endocycling, which increases the DNA content of prothoracic gland cells up to ∼64C and is a key requirement for maximal expression of the genes that are limiting for the synthesis of ecdysone ([@DEV182568C3]; [@DEV182568C51]; [@DEV182568C55]; [@DEV182568C63]). Loss of KDM5 could therefore affect ecdysone production by affecting the ability of prothoracic gland cells to endoreplicate. To test this, we quantified the number of *kdm5* mutant prothoracic gland cells undergoing S phase by incorporating the thymine nucleoside analog 5-ethynyl-2'-deoxyuridine (EdU). This revealed a significant decrease in the number of EdU-positive cells in stage-matched *kdm5^140^* larvae compared with wild type ([Fig. 5](#DEV182568F5){ref-type="fig"}A-I). Importantly, loss of KDM5 caused these endocycle defects without altering the total number of cells that comprise the prothoracic gland ([Fig. 5](#DEV182568F5){ref-type="fig"}J). The specification of these cells therefore occurs normally during embryogenesis in *kdm5* mutants, but they fail to endocycle and grow correctly during larval development. Fig. 5.***kdm5^140^* larvae have a prothoracic gland endocycle defect that is rescued by expression of *cyclin E* or *torso*.** (A-D) Control larvae in which EdU incorporation was carried out using larvae from a cross of spok\>GFP to the wild-type strain *w^1118^* to mark prothoracic gland cells. (A) GFP, (B) EdU, (C) DAPI and (D) merge of EdU and GFP channels. (E-H) *kdm5^140^* mutant larvae in which EdU incorporation was carried out using larvae of the genotype *kdm5^140^*; spok\>GFP. (E) GFP, (F) EdU, (G) DAPI and (H) merge of EdU and GFP channels. Scale bars: 50 µm. (I) Quantification of the number of EdU-positive prothoracic gland nuclei from control larvae (*n=*7 larvae) and *kdm5^140^* homozygous mutant larvae (*n=*10), *kdm5^140^;* spok*\>kdm5* (*n=*7), *kdm5^140^;* spok*\>torso* (*n=*8) and *kdm5^140^;* spok*\>cyclin E* (*n=*7). In all genotypes, prothoracic gland cells were marked using spok\>GFP. \*\*\*\**P*\<0.0001, \**P*\<0.05 (one-way ANOVA). Data are mean±s.e.m. with individual data points indicated (J) Quantification of the total prothoracic gland cell number in control spok\>GFP (*n=*12 larvae) and *kdm5^140^*; spok\>GFP (*n=*18) larvae. Data are mean±s.e.m. with individual data points indicated. ns, not significant (Student\'s *t*-test). (K) Quantification of prothoracic nuclear size expressed as a ratio to brain (diploid) nuclei from wild-type control spok\>GFP (*n=*6) and *kdm5^140^*; spok\>GFP (*n=*5) larvae. ns, not significant (Student\'s *t*-test). Data are mean±s.e.m. with individual data points indicated. (L) Western blot showing levels of KDM5 (top; indicated by arrowhead), α-tubulin (middle) and histone H3 from dissected ring glands from wild-type or *kdm5^140^* larvae. Asterisk indicates a non-specific band. (M) Quantification of three independent western blots comparing levels of histone H3 with α-tubulin. \*\**P*\<0.01. Data are mean±s.e.m. (N) Quantification of 20E levels in pg per larva using *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; spok\>*kdm5*, *kdm5^140^*; spok\>*torso* and *kdm5^140^*; spok\>*cyclin E* whole 3rd instar larvae. Data are mean±s.e.m. No significant difference between the samples was observed (one-way ANOVA). (O) Real-time PCR from biological triplicate samples quantifying the mRNA levels of the ecdysone biosynthetic gene *spok* from wild-type, *kdm5^140^*, *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; spok\>*kdm5, kdm5^140^*; spok\>*torso* and *kdm5^140^*; spok\>*cyclin E* whole 3rd instar larvae. Data are normalized to *rp49* and are shown relative to wild type. \*\**P*\<0.01, \*\*\*\**P*\<0.0001 (one-way ANOVA). Error bars indicate s.e.m. (P) Real-time PCR from biological triplicate samples quantifying the mRNA levels of the ecdysone target gene *broad* (*Br-C*) from wild-type, *kdm5^140^*, *kdm5^140^*; Ubi\>*kdm5*, *kdm5^140^*; spok\>*kdm5*, *kdm5^140^*; spok\>*torso* and *kdm5^140^*; spok\>*cyclin E* whole larvae. Data are normalized to *rp49* and are shown relative to wild type. \**P*,0.05, \*\**P*\<0.01, \*\*\**P*\<0.001, \*\*\*\**P*\<0.0001 (one-way ANOVA). Error bars indicate s.e.m. (Q) Number of days taken for pupariation to occur in wild-type (*n=*261), *kdm5^140^* (*n=*56), *kdm5^140^*; spok\>*kdm5* (*n=*73), *kdm5^140^*; spok\>*cyclin E* (*n=*48) and spok\>*cyclin E* (*n=*400) animals.

To further analyze the prothoracic gland endocycling defect of *kdm5^140^* larvae, we quantified nuclear size and levels of histone H3 in order to evaluate levels of polyploidization. These analyses revealed that the overall size of *kdm5^140^* prothoracic gland nuclei were similar to developmental stage-matched wild-type animals ([Fig. 5](#DEV182568F5){ref-type="fig"}K). However, western blot analyses of histone H3 from dissected ring glands from wild-type and *kdm5^140^* larvae revealed a significant decrease in the levels of this essential chromatin component ([Fig. 5](#DEV182568F5){ref-type="fig"}L,M). Because levels of histone H3 increase in-step with the increased amount of DNA generated with each endocycle, these data are consistent with *kdm5^140^* prothoracic gland cells having a polyploidization defect. Our observation that loss of KDM5 did not alter prothoracic gland nuclear size could additionally indicate a change in DNA compaction in these cells or that measuring nuclear size is not sensitive enough to detect modest changes to DNA content. Based on its ability to rescue the developmental delay of *kdm5^140^*, we next tested the extent to which *torso* expression in the prothoracic gland rescued the endocycling defect of *kdm5^140^*. Consistent with data linking the Torso/MAPK pathway to ecdysone production through promoting endoreduplication ([@DEV182568C63]), expression of *torso* using spok-Gal4 restored prothoracic gland endocycling in a similar manner to expression of *kdm5* ([Fig. 5](#DEV182568F5){ref-type="fig"}I). *torso* expression in *kdm5^140^* animals was also sufficient to rescue the expression of the ecdysone biosynthetic gene *spok*, levels of 20E and expression of the ecdysone response gene *broad* ([Fig. 5](#DEV182568F5){ref-type="fig"}N-P).

To directly explore the link between phenotypes caused by loss of KDM5 and reduced prothoracic gland endocycling, we drove endoreplication by overexpressing the cell cycle regulator Cyclin E ([@DEV182568C51]). spok-Gal4-mediated expression of a UAS-*cyclin E* transgene in *kdm5^140^* mutant larvae rescued several key phenotypes, including their endoreplication defect, the slowed larval development, the levels of circulating 20E, and the expression of ecdysone biosynthetic and ecdysone inducible genes ([Fig. 5](#DEV182568F5){ref-type="fig"}I,N-Q). A deficit in prothoracic gland cell endocycling is therefore likely to be a key cause of the developmental delay seen in *kdm5^140^* larvae. Significantly, in contrast to activation of the Torso/MAPK pathway, expression of *cyclin E* was not able to restore viability to *kdm5^140^* mutant animals ([Table 3](#DEV182568TB3){ref-type="table"}). KDM5 is therefore likely to regulate larval growth rate by promoting ecdysone production through prothoracic cell polyploidization. In addition, KDM5 is needed for prothoracic gland function during larval and/or pupal development in a manner that is independent of this cell cycle activity ([Fig. 6](#DEV182568F6){ref-type="fig"}). Fig. 6.**Model for KDM5 function in the prothoracic gland.** We propose that KDM5 activates the Torso/MAPK pathway to regulate the expression of ecdysone biosynthetic genes and subsequent ecdysone production, in addition to other key cellular functions.

DISCUSSION {#s3}
==========

In this study, we demonstrate that KDM5 is essential for the function of the ecdysone-producing prothoracic gland during *Drosophila* larval development. Crucial to this conclusion was our finding that expressing *kdm5* in the prothoracic gland was sufficient to rescue the lethality and developmental delay phenotypes of *kdm5^140^* null allele homozygous mutant animals. Consistent with this observation, prothoracic gland function was defective in *kdm5* mutants, with mutant larvae having low levels of ecdysone and reduced expression of downstream hormone-responsive target genes. Demonstrating the importance of KDM5-mediated regulation of ecdysone production, dietary supplementation of 20E restored normal developmental timing to *kdm5* mutant larvae. At the cellular level, loss of KDM5 slowed the prothoracic gland endoreplicative cycles that increase the ploidy of these cells and are important for ecdysone biosynthesis ([@DEV182568C51]). Restoring these endocycles by expressing *cyclin E* re-established normal developmental timing to *kdm5^140^* mutants but was not able to rescue their lethality. In contrast, ectopic activation of the Torso/MAPK pathway that functions upstream of *cyclin E* was able to restore both developmental timing and rescue the lethality caused by loss of KDM5. We therefore propose that KDM5-mediated activation of the Torso/MAPK pathway in the prothoracic gland is important for larval growth regulation through its role in promoting polyploidization, and for adult eclosion by mechanisms that remain to be determined.

Consistent with an important developmental role for KDM5-mediated regulation of Torso/MAPK, mutations in *torso* or ablation of the neurons that produce its ligand PTTH cause a 5-day delay to larval development similar to that observed for *kdm5^140^* ([@DEV182568C18]; [@DEV182568C40]; [@DEV182568C55]). Because loss of KDM5 reduces, but does not eliminate, *torso* expression, the *kdm5^140^* phenotype cannot be accounted for solely by the twofold change to Torso/MAPK signaling observed. The dysregulation of additional KDM5-regulated genes is therefore likely to contribute to the prothoracic gland phenotypes of *kdm5* mutant larvae. Little is known about the transcriptional regulation of *torso* and other genes that make up the upstream pathways that regulate ecdysone production ([@DEV182568C49]). One possibility is that KDM5 functions as a direct transcriptional activator of the *torso* gene; thus, decreased expression of this receptor would be expected in *kdm5* mutant animals. Because of the small size of the prothoracic gland, it is not currently feasible to carry out ChIP experiments to examine KDM5 promoter binding in this tissue. It is, however, notable that the *torso* promoter was not bound by KDM5 in existing ChIP-seq datasets from larval wing imaginal discs or from whole adult flies ([@DEV182568C35]; [@DEV182568C37]). This could be because *torso* expression is largely restricted to the prothoracic gland during larval development and so may not be expected to have promoter-bound KDM5 in the tissues examined to date ([@DEV182568C55]). Alternatively, KDM5 might regulate *torso* indirectly. In the silkworm *Bombyx mori*, expression of the *torso* gene is repressed in response to starvation conditions ([@DEV182568C24]). Although the mechanism by which this occurs is unknown, it does indicate that other cellular defects caused by loss of KDM5 could lead to changes to *torso* transcription and subsequent decrease in MAPK activity and ecdysone production. Whether the regulation of *torso* by KDM5 is direct or indirect, it occurs in a demethylase-independent manner, as larvae lacking enzymatic activity show a normal developmental profile ([@DEV182568C18]). Consistent with this observation, components of KDM5 complexes that regulate gene expression through demethylase-independent mechanisms also affect developmental timing. For example, a development delay similar to that of *kdm5^140^* is caused by RNAi-mediated knockdown of the histone deacetylase *HDAC1* or the NuRD complex components *asf1* and *Mi-2* ([@DEV182568C16]). KDM5 could therefore interact with these proteins to regulate the expression of genes that are crucial to the regulation of larval development.

Increased ploidy of prothoracic gland cells is important for optimal expression of steroidogenic genes and can be induced by activation of the Torso/MAPK pathway ([@DEV182568C51]; [@DEV182568C63]). Because the genes required for ecdysone biosynthesis are among the most abundantly expressed in the prothoracic gland, their mRNA levels may be entirely limited by gene copy number ([@DEV182568C14]; [@DEV182568C19]). A similar requirement for copy number amplification to produce peak gene expression levels has been observed in other cell types in *Drosophila*, including chorion gene expression in ovarian follicle cells ([@DEV182568C52]). However, it is not known how Torso/MAPK activation promotes prothoracic gland cell cycle progression. One mechanism might be by affecting levels of cell cycle regulators such as the transcription factor E2f1, which is essential for both mitotic and endoreplicative cell cycles ([@DEV182568C17]; [@DEV182568C19]; [@DEV182568C20]). This model is based on studies of the polyploid enterocytes of the adult midgut, in which activation of the MAPK pathway via the EGF receptor stabilizes E2f1 protein, leading to transcription activation of *cyclin E* ([@DEV182568C72]). Although restoring correct endocycling in *kdm5* mutant prothoracic glands was able to rescue their developmental timing, it did not impact their eclosion defect. This could be because loss of KDM5 leads to additional defects within the prothoracic gland that are ultimately detrimental to the function of this endocrine tissue, such as increased oxidative stress, which we have shown to be affected in *kdm5* hypomorphic mutant wing discs ([@DEV182568C36]). Alternatively, KDM5 could have a cell cycle independent role in maintaining ecdysone levels during pupal development. *kdm5^140^* mutant animals die as pharate adults that have no obvious morphological abnormalities but fail to eclose ([@DEV182568C18]). Nevertheless, these animals could have significant defects in, for example, nervous system development, which requires ecdysone and is important for eclosion ([@DEV182568C9]; [@DEV182568C65]).

Our observed role of KDM5 in the growth and polyploidization of larval prothoracic gland raises the possibility that it might play key roles in other cell types that use endoreplicative cycles. This could have broad consequences for our understanding of KDM5 biology, as polyploidization is observed in many plant and animal cell types and is widely used during *Drosophila* larval development ([@DEV182568C19]; [@DEV182568C52]). In addition, while the role of polyploid cells in the etiology or maintenance of cancers remains a topic of ongoing research, KDM5-regulated endocycling could contribute to its tumorigenic activities in humans. Regulation of polyploidization in cells of the nervous system could also contribute to the link between KDM5 protein dysregulation and intellectual disability ([@DEV182568C69]). This could, for example, be mediated by KDM5 function in glial cells, as polyploidization of superineurial glial cells in *Drosophila* is required for normal brain development ([@DEV182568C68]). Although it is not clear the extent to which a similar phenomenon occurs during human brain development, it is interesting to note that glial cell types contribute to the severity of intellectual disability disorders such as Rett syndrome ([@DEV182568C62]). Thus, although there is still much to be learned regarding the contribution of polyploid cells to normal development and to clinically relevant disorders, KDM5-regulated transcriptional programs could be key to the function of cells that use this variant cell cycle.

MATERIALS AND METHODS {#s4}
=====================

Care of fly strains and crosses {#s4a}
-------------------------------

Fly crosses were carried out at 25°C at 50% humidity and a 12 h light/dark cycle. Food (per liter) contained 18 g yeast, 22 g molasses, 80 g malt extract, 9 g agar, 65 cornmeal, 2.3 g methyl para-benzoic acid and 6.35 ml propionic acid. The sexes of dissected larvae for imaginal disc studies were not determined. For western blot and real-time PCR analyses, the number of male and female larvae were equal across the genotypes examined. For studies comparing wild-type and *kdm5* mutant larvae, we matched animals for developmental stage, and not chronological age, as we have done previously ([@DEV182568C18]). Thus, wild-type wandering 3rd instar larvae were ∼120 h after egg laying (AEL), while *kdm5^140^* larvae were ∼10 days old.

Real-time PCR {#s4b}
-------------

Total RNA was purified from either whole wandering 3rd instar larvae or from dissected brain-ring gland complexes using TRIzol. Reverse transcription was carried out using 1 µg of RNA (or 5 µg of RNA for ecdysone biosynthetic genes) using a Verso cDNA kit (Thermo-Fisher AB1453A). Real-time PCR used the PowerUp SYBR Green Master Mix and was performed in Applied Biosystems Step ONE plus real-time PCR system. Changes to gene expression were determined by normalizing samples to *rp49* (*RpL32*).

Western blot {#s4c}
------------

Western blots were carried out with dissected wing discs or ring glands from developmental age matched 3rd instar larvae. Samples were dissected in 1×PBS and transferred to 1×NuPAGE LDS sample buffer, run on a 4-12% Bis-Tris 1 mm gel and transferred to PVDF. Secondary antibodies were donkey anti-mouse IgG or donkey anti-rabbit IgG 800CW. Blots were scanned using a LI-COR Odyssey Infrared scanner and quantified using LI-COR imaging software v3.0. Antibody sources and dilutions can be found in [Table S1](Table S1).

Immunostaining of wing discs {#s4d}
----------------------------

3rd instar wing imaginal discs were dissected in 1×PBS and fixed in 4% paraformaldehyde for 30 min. After blocking in 0.1% BSA/TBST (1×PBS, 0.2% Triton and 0.1% BSA) for 1 h, samples were incubated with anti-Dcp-1 antibodies or anti-pH3 antibodies overnight at 4°C. Wing discs were washed with PBST and incubated with anti-rabbit Alexa Fluro 568 secondary antibody for 2 h at 4°C. Samples were mounted in Vectashield for microscopy. To compare wild-type and *kdm5^140^* staining, the number of Dcp-1- and pH3-positive cells within the pouch region of wing discs was quantified. We have previously shown that stage-matched *kdm5^140^* larvae have discs that are the same size as wild type ([@DEV182568C18]). Antibody sources and dilutions can be found in Table S1.

Edu incorporation into larval tissues {#s4e}
-------------------------------------

For EdU staining, click-IT EdU kit and Alexa Fluor 594 Azide were used. Wild-type or *kdm5^140^* larvae that were matched for developmental time at the 3rd instar larvae were dissected in Schneider\'s *Drosophila* medium. Brain-ring gland complexes were then in incubated in 50 µM EdU in Schneider\'s Drosophila medium for 2.5 h at room temperature. After washing in 1×PBS, tissues were fixed in 4% paraformaldehyde for 30 min. Tissues were blocked in 3% BSA for 30 min and then permeabilized in 0.5% triton and detected using 1× click-IT reaction buffer, CuSO4, Alexa Fluor 594 Azide and reaction buffer additive for 30 min. DNA was stained using 4′,6-diamidino-2-phenylindole (DAPI) and samples were mounted in Vectashield for microscopy.

Larval feeding of 20E or 7-dehydrocholesterol {#s4f}
---------------------------------------------

Control wild-type or *kdm5^140^*/CyO-GFP flies were allowed to mate and lay eggs for 6 h. At 96 h after egg laying (AEL), a mixture of dry yeast, 20-hydroxyecdysone (0.33 mg/ml in 100% ethanol) or control ethanol alone in 500 µl of double-distilled H~2~O was added to each vial. For feeding 7-dehydrocholesterol (7dC), an established protocol was used in which a mixture of 50 mg yeast, 95 µl water and 5 µl 100% ethanol, and 0.75 mg 7-hydroxycholesterol was added to 30 h AEL larvae in vials that were shielded from light ([@DEV182568C76]). *kdm5^140^* homozygotes were identified using the *Cy*O-GFP balancer chromosome.

20E quantification {#s4g}
------------------

Ecdysone was extracted from whole larvae as previously described ([@DEV182568C43]). Briefly, ten 3rd instar larvae were washed in double-distilled H~2~O and then homogenized in 0.5 ml methanol. After centrifugation, the pellet was re-extracted in 0.5 ml methanol and then in 0.5 ml ethanol. The three supernatants were mixed and 0.5 ml was evaporated using a SpeedVac. The pellet was dissolved in 100 µl of EIA buffer and subjected to the 20-hydroxyecdysone EIA Kit.

Lifespan analyses {#s4h}
-----------------

Lifespan analyses were carried out by collecting adult flies 24-36 h after eclosion and placing flies into vials at a density of 20 animals or fewer. Survival was quantified by counting the number of dead animals every day and transferring living flies into vials with fresh food every 2 days. Lifespan analyses were carried out using Log-rank (Mantel-Cox) test in Prism v8.0.

Developmental delay quantification {#s4i}
----------------------------------

Female and male flies were placed in a vial and allowed to lay eggs for 16 h. Starting at day 4 days AEL (or 3 days AEL for spok-Gal4 crosses in a wild-type background), the number of animals that had pupariated were scored every 24 h. Pupal genotype was ascertained by balancing *kdm5^140^* using a *Cy*O-GFP chromosome.

Prothoracic gland size nuclear size determination {#s4j}
-------------------------------------------------

The ploidy of prothoracic gland nuclei was estimated by comparing their size with that of diploid brain nuclei, similar to published studies ([@DEV182568C51]). Nuclear size of prothoracic gland and brain lobe nuclei were determined using Image J ([@DEV182568C60]). For each larva examined, the size of at least three prothoracic gland nuclei and three brain nuclei were averaged, and the ratio between the two tissues determined. At least five larvae were examined for wild type and *kdm5^140^*.

Fertility analyses {#s4k}
------------------

To determine fertility, individual female flies were placed in a vial with five wild-type male flies and individual males were placed in a vial with three to five virgin wild-type females and allowed to mate and lay eggs for 4 days. If larvae were present in the vial by day 5, the fly was designated fertile. In cases where the fly died before day 3, we were unable confidently assess fertility and these animals were eliminated from the analyses.

Image acquisition and processing {#s4l}
--------------------------------

Adult fly images were obtained using Zeiss Discovery.V12 SteREO or ZEISS ApoTome microscopes and captured using AxioVision Release 4.8 software. Images of larval tissues were obtained using Zeiss AxioImager.M12 microscope and AxioVision SE64 Release 4.9.1 software. All images were processed using Adobe Photoshop CC 2019.

Statistical analyses {#s4m}
--------------------

All experiments were carried out in biological triplicate (minimum) and numbers (*n*) are provided for each experiment. Fisher\'s exact test was carried out in R. Student\'s *t*-test, one-way ANOVA and Wilcoxon rank-sum tests were carried out using GraphPad Prism.

Resource and primer information {#s4n}
-------------------------------

Resource and primer details can be found in [Tables S1](Tables S1) and [S2](S2).
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